Home » Q&A: Pfizer's Dominic Spinella on the Challenges of Using NGS in Clinical Trials

Q&A: Pfizer's Dominic Spinella on the Challenges of Using NGS in Clinical Trials

Jun 21, 2011
Premium

Dom Spinella picture.jpgName: Dominic Spinella
Title: Head of translational and molecular medicine at Pfizer Biotherapeutics Division
Experience: Head of translational medicine, Pfizer Oncology
Faculty in the department of medicine and microbiology and immunology, University of Tennessee Medical School
La Jolla site head of experimental medicine, Pfizer

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

DNA Tests Considered to Verify Relatedness at Border

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

First of 'Right to Try'

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

This Week in Nature

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

How Old Were They?

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.

Jun
28
Featured Webinar

An Optimized NGS Workflow for Human Metagenomic Analysis

Sponsored by
PerkinElmer

This webinar will review a standardized, high-throughput, and fully automated library prep protocol for human metagenomic analysis.

What's Popular?

In Clinical Sequencing

  1. Roche to Acquire Outstanding Shares of Foundation Medicine for $2.4B

  2. Mayo Team Describes Clinical RNA Sequencing Assay for Oncogenic Fusions

    Premium

  3. Natera, Institut Jules Bordet Ink Breast Cancer Research Collaboration

  4. Exome Sequencing Helps Diagnose Primary Antibody Deficiency Patients

  5. Evidence Builds for Cell-Free DNA Testing to Diagnose Infection in Transplant Patients

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.